Skip to main content
OpenTrials

Clinical trial condition

Herpes Genitalis

Explore clinical trials studying Herpes Genitalis. Study availability and eligibility vary by location and protocol.

53 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Herpes Genitalis trial results

Completed

Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes

NCT01687595

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +14 more
Locations
  • Westover Heights Clinic Portland, Oregon, United States
  • Center for Clinical Studies - Texas Medical Center Houston, Texas, United States
  • Center for Clinical Studies - Cypress Houston, Texas, United States
  • Center for Clinical Studies- Webster Houston, Texas, United States
View Trial Details
Completed

Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes

NCT01281007

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +18 more
Locations
  • Centro de Medicina Reprodutiva Dr Carlos Isaia Filho Ltda Porto Alegre, Rio Grande do Sul, Brazil
  • Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil
  • SPVita Bragança Paulista, São Paulo, Brazil
  • Caep Centro Avancado de Estudos E Pesquisas Ltda Campinas, São Paulo, Brazil
View Trial Details
Completed

The VIBLOK SAfety and perFormancE Trial

NCT03080961

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +15 more
Locations
  • EB FlevoResearch Almere Stad, Flevoland, Netherlands
  • PT&R Beek, Limburg, Netherlands
  • EB UtrechtResearch Utrecht, Netherlands
View Trial Details
Completed

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

NCT02837575

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +17 more
Locations
  • Alabama Vaccine Research Clinic at University of Alabama at Birmingham Birmingham, Alabama, United States
  • Medical Center for Clinical Research San Diego, California, United States
  • QPS Broward Research Hollywood, Florida, United States
  • QPS Miami Research Associates South Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

NCT00158860

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +13 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Anaheim, California, United States
View all 72 locations
View Trial Details

Related conditions